Ernexa Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Ernexa Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ERNA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000748592
Board of directors
-
Brant Binder · DirectorSince 2023
-
Dorothy J. Clarke · Director · General CounselSince 2023
-
Elena Ratner · DirectorSince 2025
-
James Arthur Bristol · DirectorSince 2023
-
Matthew Angel · Director · President and CEOSince 2023
-
Peter Cicala · DirectorSince 2024
-
Richard W. Wagner · DirectorSince 2023
-
Sanjeev Luther · Director · President & CEOSince 2024
-
William A. Wexler · DirectorSince 2025
Chief executives
Sanjeev Luther
· President and CEO
Since January 2024
Matthew Angel
· President and CEO
Until January 2024
· Former
Board connections
2 of this board's directors also sit on 2 other boards.
- via James Arthur Bristol
- via Matthew Angel
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $2,000,000
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 10, 2026 | Cherington Charles 10% owner | Open-market purchase | +4,000,000 | $0.50 | $2,000,000 |
| Jun 21, 2025 | Gurrola Sandra M Officer (Sr. VP of Finance) | Option exercise | +30 | — | — |
| Jun 9, 2025 | Cherington Charles 10% owner | Open-market purchase | +21,241,163 | $0.10 | $2,124,116 |
| Apr 2, 2025 | Cherington Charles 10% owner | Open-market purchase | +3,768,397 | $0.10 | $376,840 |
| Oct 29, 2024 | Cherington Charles 10% owner | Open-market purchase | +261,756 | — | — |
| Oct 29, 2024 | Cherington Charles 10% owner | Open-market purchase | +4,768,783 | — | — |
| Oct 29, 2024 | Cherington Charles 10% owner | Open-market purchase | +1,237,762 | — | — |
| Oct 29, 2024 | Cherington Charles 10% owner | Open-market purchase | +5,420,823 | — | — |
| Oct 29, 2024 | Cherington Charles 10% owner | Open-market purchase | +1,562,988 | — | — |
| Oct 29, 2024 | Cherington Charles 10% owner | Derivative conversion | +2,819,546 | $0.50 | $1,409,773 |
| Jun 21, 2024 | Gurrola Sandra M Officer (Sr. VP of Finance) | Option exercise | +437 | — | — |
| Jun 21, 2024 | Gurrola Sandra M Officer (Sr. VP of Finance) | Shares withheld for tax | −180 | $1.94 | $349 |
| Jun 21, 2023 | Gurrola Sandra M Officer (Vice President of Finance) | Option exercise | +438 | — | — |
| Jun 21, 2023 | Gurrola Sandra M Officer (Vice President of Finance) | Shares withheld for tax | −179 | $2.48 | $444 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.